Peptidyl Prolyl Isomerase PIN1 Directly Binds to and Stabilizes Hypoxia-Inducible Factor-1α

• Hyeong-jun Han,

  Affiliations Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, 151–742, South Korea, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, 151–742, South Korea

  ⨯
• Nayoung Kwon,

  Affiliation Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, 151–742, South Korea

  ⨯
• Min-A Choi,

  Affiliation Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, 151–742, South Korea

  ⨯
• Kyung Oh Jung,

  Affiliations Department of Nuclear Medicine, Seoul National University, Seoul, 136–742, South Korea, Biomedical Sciences, Seoul National University, Seoul, 136–742, South Korea, Cancer Research Institute, Seoul National University, Seoul, 136–742, South Korea

  ⨯
• Juan-Yu Piao,

  Affiliations Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, 151–742, South Korea, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, 151–742, South Korea

  ⨯
• Hoang Kieu Chi Ngo,

  Affiliations Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, 151–742, South Korea, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, 151–742, South Korea

  ⨯
• Su-Jung Kim,

  Affiliations Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, 151–742, South Korea, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 151–742, South Korea

  ⨯
• Do-Hee Kim,

  Affiliation Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, 151–742, South Korea

  ⨯
• June-Key Chung,

  Affiliations Department of Nuclear Medicine, Seoul National University, Seoul, 136–742, South Korea, Biomedical Sciences, Seoul National University, Seoul, 136–742, South Korea, Cancer Research Institute, Seoul National University, Seoul, 136–742, South Korea

  ⨯
• Young-Nam Cha,

  Affiliation College of Medicine, Inha University, Incheon, South Korea

  ⨯
• Hyewon Youn,

  Affiliations Department of Nuclear Medicine, Seoul National University, Seoul, 136–742, South Korea, Cancer Research Institute, Seoul National University, Seoul, 136–742, South Korea, Cancer Imaging Center, Seoul National University Hospital, Seoul, 136–742, South Korea

  ⨯
• Bu Young Choi,

  Affiliation Department of Pharmaceutical Science and Engineering, School of Convergence Bioscience and Technology, Seowon University, Cheongju, 361–742, South Korea

  ⨯
• Sang-Hyun Min,

  Affiliation New Drug Development Center DGMIF, Daegu, 701–310, South Korea

  ⨯
• Young-Joon Surh

  * E-mail: surh@snu.ac.kr

  Affiliations Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, 151–742, South Korea, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, 151–742, South Korea, Cancer Research Institute, Seoul National University, Seoul, 136–742, South Korea, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, 151–742, South Korea

  ⨯